Blood Cancer Talks

In this episode, we discuss the latest updates on CAR T-cell therapy in multiple myeloma, including the studies presented at ASCO and EHA 2023. Here are the show notes:

1. For a primer on CAR T-cell therapy, listen to our episode aired on July 22nd 2022 with Dr. Surbhi Sidana:

2. RCTs of BCMA CAR T-cell Therapy in Early Relapsed Multiple Myeloma:
a) KarMMa-3 (ide-cel):
b) CARTITUDE-4 (cilta-cel):

3. Clinical trials of GPRC5D CAR T-cell therapy in multiple myeloma:
a) MCARH109 (MSKCC Trial):
b) POLARIS Trial:

3. Phase 1 UNIVERSAL trial of ALLO-715 in Multiple Myeloma:

4. Anti BCMA/CD19 CAR T-cells with IMiD maintenance therapy in myeloma:


What is Blood Cancer Talks?

This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will bring a wide range of experts within hematologic malignancies to discuss various topics in depth.
Host: Raj Chakraborty, MD from Columbia University, New York, Ashwin Kishtagari, MD, from Vanderbilt University, Nashville, and Edward Cliff, MD, from Harvard University, Boston
Tweet your suggestions and feedback to @rajshekharucms @AshKishtagari @Eddie_Cliff @BloodCancerTalk